Profile
| Metric | Value |
|---|---|
| Full Name | Medtronic plc |
| Ticker | NYSE: MDT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | Ireland |
| IPO | |
| Indexes | |
| Website | medtronic.com |
| Employees | 95,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $96.42 | |
| Price, 1D Change | -0.55% | |
| Market Cap | $124B | |
| TTM Dividend Yield | 2.94% | |
| PE Ratio | 26.05 | |
| Beta | 0.44 | |
| Revenue | $34B | |
| Revenue, 1Y Change | +3.62% | |
| EPS | $3.61 | |
| EPS, 1Y Change | +30.78% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.71 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.61 | |
| EPS Estimate | N/A | $5.65 |
| EPS Est. Change | N/A | +56.40% |
| Revenue | $33.54B | |
| Revenue Estimate | N/A | $36.05B |
| Revenue Est. Change | N/A | +7.49% |
| Current Price | $96.42 | |
| Price Target | - | $112.00 |
| Price Tgt. Change | - | +16.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.20 | $2.76 | -46.86% | |
| $5.46 | $3.61 | -33.75% | |
| $5.65 | N/A | +56.40% | |
| $6.11 | N/A | +69.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $32.24B | $32.36B | +0.40% | |
| $33.49B | $33.54B | +0.14% | |
| $36.05B | N/A | +7.49% | |
| $38.09B | N/A | +13.57% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +17.89% | |
| Price, 3Y | +19.64% | |
| Market Cap, 1Y | +17.86% | |
| Market Cap, 3Y | +15.31% | |
| Revenue, 1Y | +3.62% | |
| Revenue, 3Y | +5.84% | |
| EPS, 1Y | +30.78% | |
| EPS, 3Y | -3.07% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $96.42 | |
| SMA 200 | $91.59 | |
| SMA 200 vs Price | -5.01% | |
| SMA 50 | $98.03 | |
| SMA 50 vs Price | +1.67% | |
| Beta | 0.44 | |
| ATR | $1.65 | |
| 14-Day RSI | 42.49 | |
| 10-Day Volatility | 20.61% | |
| 1-Year Volatility | 21.76% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.71 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.90% | |
| Total Dividend | $2.80 | |
| Dividends Paid | $3.59B | |
| Payout Ratio | 76.49% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $33.54B | |
| EPS | $3.61 | |
| Gross Profit | $20.05B | |
| Gross Margin | 59.78% | |
| Operating Profit | $6.19B | |
| Operating Margin | -21.75% | |
| Net Income | $4.69B | |
| Net Margin | 13.99% | |
| EBITDA | $9.05B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.62 | |
| Current Ratio | 1.85 | |
| Quick Ratio | 1.42 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 2.92 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 26.05 | |
| PS Ratio | 3.56 | |
| PB Ratio | 2.54 | |
| EV/EBITDA | 15.22 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $48.02B | |
| Cash & Equivalents | $8.97B | |
| Total Assets | $91.68B | |
| Current Assets | $23.81B | |
| Total Liabilities | $43.42B | |
| Current Liabilities | $12.88B | |
| Total Debt | $29.63B | |
| Short Term Debt | $3.07B | |
| Accounts Payable | $2.45B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $28.88B | |
| Operating Expenses | $13.86B | |
| Cost Of Goods Sold | $13.49B | |
| SG&A | $10.85B | |
| D&A | $2.86B | |
| Interest Expense | $0.00 | |
| Income Tax | $936.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $7.04B | |
| CFI | -$1.94B | |
| CFF | -$4.36B | |
| Capex | $1.86B | |
| Free Cash Flow | $5.19B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Bernstein | → | |
| Barclays | → | |
| William Blair | → | |
| Truist Securities | → | |
| Truist Securities | → | |
| Barclays | → | |
| Wells Fargo | → | |
| UBS | → | |
| RBC Capital | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with MDT
Data Sources & References
- MDT Official Website www.medtronic.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1613103/000162828025052771/0001628280-25-052771-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- MDT Profile on Yahoo Finance finance.yahoo.com/quote/MDT
- MDT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdt
FAQ
What is the ticker symbol for Medtronic plc?
The ticker symbol for Medtronic plc is NYSE:MDT
Does Medtronic plc pay dividends?
Yes, Medtronic plc pays dividends. The last payment was $0.71, with an ex-dividend date on December 26, 2025
What sector is Medtronic plc in?
Medtronic plc is in the Healthcare sector
What industry is Medtronic plc in?
Medtronic plc is in the Medical Devices industry
What country is Medtronic plc based in?
Medtronic plc is headquartered in Ireland
When did Medtronic plc go public?
Medtronic plc initial public offering (IPO) was on May 2, 1973
Is Medtronic plc in the S&P 500?
Yes, Medtronic plc is included in the S&P 500 index
Is Medtronic plc in the NASDAQ 100?
No, Medtronic plc is not included in the NASDAQ 100 index
Is Medtronic plc in the Dow Jones?
No, Medtronic plc is not included in the Dow Jones index
When was Medtronic plc last earnings report?
Medtronic plc's most recent earnings report was on November 18, 2025
When does Medtronic plc report earnings?
The next expected earnings date for Medtronic plc is February 17, 2026
